1. "Survivorship Research"
Formats
  1. Journal Article (8900)
  2. Meeting Abstract (5192)
  3. Book Section (571)
  4. Review (357)
  5. Editorial (225)
  6. Research Letter (132)
  7. Conference Paper (104)
  8. Correspondence (91)
  9. Guidelines (85)
  10. Miscellaneous (76)
  11. Book Whole (30)
Groups
  1. Survivorship Research (15763)
  2. Department of Medicine (9202)
  3. Population Sciences Research Program (5670)
  4. Solid Tumor Oncology Division (5184)
  5. Surgery (5131)
  6. Epidemiology and Biostatistics (3598)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (788)
  3. Michael Zelefsky (754)
  4. Sergio Giralt (684)
  5. Mark Robson (676)
  6. Joachim Yahalom (625)

More People

Years
  1. 2025 (231)
  2. 2024 (802)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (930)

More Years

Publications
  1. Journal of Clinical Oncology (1873)
  2. International Journal of Radiation Oncology, Biology, Physics (908)
  3. Blood (685)
  4. Annals of Surgical Oncology (599)
  5. Cancer Research (333)
  6. Cancer (331)

More Publications

Publishers
  1. Elsevier Inc. (2658)
  2. American Society of Clinical Oncology (2019)
  3. Springer (1542)
  4. Wiley Blackwell (806)
  5. Oxford University Press (787)
  6. American Society of Hematology (748)

More Publishers

Results (15763)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MicroRNA as novel blood-based biomarkers in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mikkilineni, N.; Fiegoli, B.; Blass, S.; Grigoryev, Y.; Viale, A.; Socci, N. D.; Voss, M. H.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • DNA repair capacity and tumor recurrence in patients with non-muscle-invasive bladder cancer (NMIBC)
    Meeting Abstract

    Donahue, T. F.; Donat, S. M.; Patel, H.; Chou, J. F.; Bayuga, S.; Olson, S. H.; Zerillo, J. A.; Dominguez, G.; Leoce, N. M.; Herr, H. W.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A comparison of toxicity of gemcitabine versus platinum-based combined chemoradiation for muscle-invasive bladder cancer: The Memorial Sloan-Kettering experience
    Meeting Abstract

    Baliga, S.; Pei, X.; Bajorin, D. F.; Rosenberg, J. E.; Bochner, B.; Kollmeier, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Risk assessment for severe hypocalcemia requiring hospitalization with denosumab
    Meeting Abstract

    Autio, K. A.; Farooki, A.; Glezerman, I.; Chan, A.; Barr, H. C.; Seyboth, B. M.; Schneider, C. W.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Exome sequencing of extreme phenotypes to identify variants predictive of response to chemotherapy in bladder cancer
    Meeting Abstract

    Alanee, S.; Shah, S.; Stratton, K. L.; Garcia-Grossman, I. R.; Zabor, E.; Ostrovnaya, I.; Joseph, V.; Pendse, D.; Bajorin, D. F.; Offit, K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Identification of changing melanocytic lesions in patients on BRAF inhibitor therapy
    Meeting Abstract

    Yagerman, S.; Flores, E.; Marghoob, A. A.; Lacouture, M. E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • TBCRC 019: An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab (TIG) in patients with metastatic triple negative breast cancer (TNBC)
    Meeting Abstract

    Vakiavas, C.; Abramson, V. G.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; Traina, T. A.; Li, Y.; Patil, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Hyaluronidase synthase 3 (HAS3) variant and anthracycline-related cardiomyopathy: A report from the Children's Oncology Group
    Meeting Abstract

    Sun, C. L.; Wang, X.; Liu, W.; Armenian, S.; Hankonarson, H.; Hageman, L.; Ding, Y.; Landier, W.; Keller, F. G.; Neglia, J. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of doxorubicin and cyclophosphamide (AC) versus single-agent paclitaxel (T) as adjuvant therapy for breast cancer in women with 0-3 positive axillary nodes: CALGB 40101
    Meeting Abstract

    Shulman, L. N.; Berry, D. A.; Cirrincione, C. T.; Becker, H.; Perez, E. A.; O'Regan, R.; Martino, S.; Shapiro, C. L.; Atkins, J.; Schneider, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save